Anavex Life Sciences Corp at JPMorgan Healthcare Conference Transcript
All right, we'll go ahead and get started. Good morning, everyone. My name is Lolita, and it's my pleasure to introduce the speaker for the Anavex presentation today, President and CEO of Anavex, Dr. Christopher Missling. With that, Christopher, I'll turn it over to you.
&
Thank you very much for the kind introduction, and it's very kind of you to get us invited to this conference. We're very excited about presenting today Anavex Life Sciences. We're a public company, so we'd like you to read the forward-looking statement. Thank you.
So, Anavex is dedicated to creating scalable drug therapies that are both easy to administer and accessible. We are contributing to the sustainability of global healthcare as well. Our commitment is that cutting-edge CNS treatments are available to a diverse patient population, ultimately enhancing the effectiveness and reach of healthcare systems. We believe that this focus on accessibility and sustainability represents
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
